![](/img/cover-not-exists.png)
Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin
Andersson, Y, Engebraaten, O, Juell, S, Aamdal, S, Brunsvig, P, Fodstad, Ø, Dueland, SVolume:
113
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2015.380
Date:
December, 2015
File:
PDF, 482 KB
english, 2015